Novartis Ag earnings were $12.9B for the trailing 12 months ending Mar 31, 2025, with -12.6% growth year over year. The latest NVS earnings report on Mar 31, 2025 announced Q1 2025 earnings of $3.6B, up 28% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NVS reported annual earnings of $11.9B, with -19.6% growth.
NVS past earnings growth
How has NVS's earnings growth performed historically?
On NVS's earnings call on Invalid Date, Novartis Ag (NYSE: NVS) reported Q1 2025 earnings per share (EPS) of $1.83, up 39.69% year over year. Total NVS earnings for the quarter were $3.61 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $1.31.
As of the last Novartis Ag earnings report, Novartis Ag is currently profitable. Novartis Ag's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $12.86 billion, a 15.65% decrease year over year.
What was NVS's earnings growth in the past year?
As of Novartis Ag's earnings date in Invalid Date, Novartis Ag's earnings has grown -12.62% year over year. This is 380.21 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 367.59%. NVS earnings in the past year totalled $12.86 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.